Ipratropium bromide in patients with nocturnal asthma.

Ipratropium bromide in children with asthma.

Eighteen children between 6 and 14 years of age with perennial asthma were studied over two four-week treatment periods. Ipratropium bromide, given in addition to their current treatment, was compared with placebo using a double-blind crossover technique. The period of treatment with ipratropium was associated with a significant reduction in symptoms during both day and night and significantly ...

Sodium cromoglycate and ipratropium bromide in exercise-induced asthma.

In thirteen patients with extrinsic asthma the effects of placebo, sodium cromoglycate, ipratropium bromide, and ipratropium bromide plus sodium cromoglycate were studied in a random double-blind fashion to assess their inhibitory action in exercise-induced asthma (EIA). Exercise testing consisted of steady state running on an inclined treadmill for up to eight minutes. In eight of the 13 patie...

Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity.

Motor neurone disease: can we do better? A study of 42 patients D J Oliver, MRCGP; N E Early, DRCOG; Barbara A Thornley, FFARCS; C W Roy, MRCP; Mary C P Groves, MB............ 828 Ablative radioiodine therapy for hyperthyroidism: a long term follow up study R E Young, MRCP, and A J Hedley, FRCPED 829 Prospective comparison of three non-invasive tests for pancreatic disease I Cobden, MB, and oth...

Ipratropium bromide: are patients treated with optimal therapy?

A double-blind crossover placebo controlled study was performed on 20 patients with stable chronic asthma, in order to obtain dose response data to ipratropium bromide (40, 80, 200 micrograms) given by metered dose inhaler. The use of the 200 micrograms dose gave a significantly greater peak effect and duration of action than the recommended standard therapeutic dose of 40 micrograms. There wer...

Ipratropium bromide bronchodilator solution.